A new study has identified key factors that influence long-term weight loss in patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes...
READ MORE
According to preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2024 in Chicago, nearly 74% of adults with treatment-resistant high blood pressure...
READ MORE
Eli Lilly is making significant strides in developing efsitora alfa, a once-weekly insulin for treating type 2 diabetes. With positive preliminary results from two pivotal studies, Lilly is
READ MORE
Using optical coherence tomography (OCT) to guide stent implantation during percutaneous coronary intervention (PCI) in patients with complex coronary lesions significantly improves surviva
READ MORE
A study presented at the ESC Congress reveals that performing additional catheter ablations targeting diseased myocardium, alongside the standard pulmonary vein isolation (PVI) approach, do
READ MORE
A study comparing an invasive strategy with optimal medical therapy alone in older adults following a non-ST-elevation myocardial infarction (NSTEMI) found no impact on the combined risk o
READ MORE
According to research presented at the ESC Congress 2024 in London, screening for atrial fibrillation (AF) with a wearable heart monitor over a two-week period can identify older adults wit
READ MORE
A pooled analysis of three major trials presented at #ESCCongress2024 did not show significant reductions in cardiovascular death with finerenone. However, significant decreases in al
READ MORE
Adherence to atrial fibrillation (AF) guideline recommendations in clinical practice across Europe was found to be poor, but a structured educational programme for healthcare professionals
READ MORE
Advancements in medical imaging have significantly improved the detection and management of various diseases. One emerging trend is the use of automated computed tomography (CT) imaging to p
READ MORE
![Medtronic Secures CE Mark for Innovative Pulmonary Valve Replacement System for Congenital Heart Disease"](https://res.cloudinary.com/healthmanagement-org/image/upload/c_thumb,f_auto,fl_lossy,h_100,q_90,w_100/v1736278991/cw/00129025_cw_image_wi_87dba3e3d5217851f249d0509c004718.webp "Medtronic Secures CE Mark for Innovative Pulmonary Valve Replacement System for Congenital Heart Disease"")
